Linh T Dang, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · Indian Health Center of Santa Clara Valley
Looking this up.
Hospitals listed: 557754 · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A115515 · Current
Licensed to practise in California · since 2011 · expires 2028-07-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$43,456
Medicare paid this office $43,456 for 138 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 78 | $13,159 | $101 |
| Long return visit (40+ min) | 51 | $11,766 | $151 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $6,276 | $153 |
| Short return visit (20+ min) | 37 | $3,410 | $76 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 71 | $1,718 | $15 |
See all 7 services
| Return visit (30+ min) | 78 | $13,159 | $101 |
| Long return visit (40+ min) | 51 | $11,766 | $151 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $6,276 | $153 |
| Short return visit (20+ min) | 37 | $3,410 | $76 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 71 | $1,718 | $15 |
| Influenza vaccine split virus, preservative free | 12 | $982 | $82 |
| Administration of influenza virus vaccine | 14 | $573 | $38 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
138 Original Medicare patients in 2024. Average age 75 · Women 72% · Also on Medicaid 11% · Health risk score 1.12. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 67% · Diabetes 28% · Coronary heart disease 22% · Chronic kidney disease 17% · Depression 17% · Cancer 14% · Atrial fibrillation 14% · Heart failure 12% · Stroke 8%.
The office billed $151,427, Medicare allowed $57,649 and paid $43,456; for 517 services of 34 kinds; $3,276 of it was for drugs given in the office and $40,180 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 138 | 517 | 75 | 1.12 | $151,427 | $43,456 |
| 2023 | 107 | 314 | 74 | 1.07 | $110,811 | $33,898 |
| 2022 | 106 | 333 | 73 | 0.95 | $120,336 | $36,262 |
| 2021 | 91 | 252 | 75 | 0.98 | $91,820 | $26,587 |
| 2020 | 83 | 224 | 74 | 1.06 | $71,350 | $17,007 |
| 2019 | 85 | 233 | 74 | 1.33 | $79,636 | $18,741 |
| 2018 | 54 | 151 | 75 | 1.08 | $42,336 | $10,743 |
| 2017 | 65 | 111 | 74 | 0.96 | $32,735 | $7,802 |
| 2016 | 33 | 64 | 74 | 1.23 | $15,003 | $4,409 |
| 2014 | 32 | 190 | 66 | 0.79 | $5,765 | $2,127 |
| 2013 | 21 | 145 | 69 | 1.25 | $4,635 | $1,741 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 74 | $14,288 | $110 |
| Long return visit (40+ min) | 27 | $5,910 | $144 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,301 | $156 |
| Influenza vaccine split virus, preservative free | 16 | $1,216 | $72 |
| Short return visit (20+ min) | 16 | $1,115 | $70 |
| Administration of influenza virus vaccine | 16 | $628 | $37 |
2022: 9 services
| Return visit (30+ min) | 69 | $12,782 | $109 |
| Long return visit (40+ min) | 30 | $8,035 | $155 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,649 | $159 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,613 | $278 |
| New patient visit (45+ min) | 17 | $2,014 | $118 |
| Short return visit (20+ min) | 17 | $1,495 | $79 |
| Influenza vaccine split virus, preservative free | 14 | $930 | $66 |
| Administration of pneumococcal vaccine | 15 | $562 | $37 |
| Administration of influenza virus vaccine | 15 | $536 | $36 |
2021: 5 services
| Return visit (30+ min) | 66 | $10,447 | $112 |
| Long return visit (40+ min) | 31 | $8,559 | $171 |
| Short return visit (20+ min) | 11 | $1,132 | $94 |
| Influenza vaccine split virus, preservative free | 12 | $779 | $65 |
| Administration of influenza virus vaccine | 15 | $328 | $22 |
2020: 5 services
| Return visit (30+ min) | 48 | $7,428 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,209 | $105 |
| Short return visit (20+ min) | 20 | $1,956 | $72 |
| Influenza vaccine split virus, preservative free | 13 | $842 | $60 |
| Administration of influenza virus vaccine | 16 | $355 | $21 |
2019: 4 services
| Return visit (30+ min) | 61 | $10,288 | $96 |
| Long return visit (40+ min) | 13 | $1,531 | $96 |
| Short return visit (20+ min) | 14 | $947 | $68 |
| Administration of influenza virus vaccine | 15 | $308 | $21 |
2018: 4 services
| Return visit (30+ min) | 31 | $4,478 | $93 |
| Short return visit (20+ min) | 14 | $928 | $58 |
| Administration of influenza virus vaccine | 13 | $334 | $26 |
| Administration of pneumococcal vaccine | 11 | $283 | $26 |
2017: 2 services
| Return visit (30+ min) | 50 | $5,021 | $82 |
| Short return visit (20+ min) | 18 | $815 | $45 |
2016: 2 services
| Return visit (30+ min) | 16 | $1,677 | $93 |
| Short return visit (20+ min) | 15 | $1,076 | $67 |
2014: 4 services
| Blood test, lipids (cholesterol and triglycerides) | 15 | $229 | $13 |
| Blood test, comprehensive group of blood chemicals | 15 | $223 | $12 |
| Insertion of needle into vein for collection of blood sample | 25 | $103 | $3 |
| Manual urinalysis test with examination using microscope, automated | 14 | $76 | $4 |
2013: 3 services
| Blood test, lipids (cholesterol and triglycerides) | 14 | $219 | $15 |
| Insertion of needle into vein for collection of blood sample | 17 | $68 | $3 |
| Manual urinalysis test with examination using microscope, automated | 11 | $51 | $4 |
Medicaid work
$96,976 in 2024
Medicaid paid $96,976 for 811 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 370 | $93,528 |
| Short return visit (20+ min) | 414 | $3,289 |
| Return visit (30+ min) | 27 | $158 |
| 2024 | 811 | 3 | 49 | $96,976 |
| 2023 | 1,038 | 5 | 71 | $106,899 |
| 2022 | 778 | 3 | 63 | $78,931 |
| 2021 | 1,228 | 4 | 65 | $133,252 |
| 2020 | 1,166 | 5 | 83 | $130,189 |
| 2019 | 1,026 | 4 | 76 | $130,376 |
| 2018 | 867 | 2 | 63 | $142,574 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 434 | $105,082 |
| Short return visit (20+ min) | 415 | $1,061 |
| Return visit (30+ min) | 157 | $726 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 16 | $18 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 16 | $11 |
2022
| Clinic visit/encounter, all-inclusive | 335 | $77,716 |
| Short return visit (20+ min) | 397 | $1,086 |
| Return visit (30+ min) | 46 | $128 |
2021
| Clinic visit/encounter, all-inclusive | 561 | $131,755 |
| Short return visit (20+ min) | 532 | $1,159 |
| Short return visit | 108 | $189 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 27 | $150 |
2020
| Clinic visit/encounter, all-inclusive | 562 | $128,552 |
| Short return visit (20+ min) | 473 | $1,394 |
| Short return visit | 93 | $243 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 26 | $0 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 12 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 584 | $128,679 |
| Short return visit (20+ min) | 401 | $1,341 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 20 | $258 |
| Short return visit | 21 | $98 |
2018
| Clinic visit/encounter, all-inclusive | 571 | $126,980 |
| Short return visit (20+ min) | 296 | $15,595 |
Drugs they prescribed that Part D paid
$132,974
Pharmacies billed $132,974 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,294 generic and fewer than 11 brand-name prescriptions · $132,974 in drug cost · 44 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 17 | $25,850 | $1,521 |
| Rybelsus | 12 | $22,199 | $1,850 |
| Eliquis | 21 | $13,054 | $622 |
| Qvar Redihaler | 13 | $4,096 | $315 |
| Amiodarone | 13 | $1,303 | $100 |
See all 39 drugs
| Jardiance | 17 | $25,850 | $1,521 |
| Rybelsus | 12 | $22,199 | $1,850 |
| Eliquis | 21 | $13,054 | $622 |
| Qvar Redihaler | 13 | $4,096 | $315 |
| Amiodarone | 13 | $1,303 | $100 |
| Gabapentin | 44 | $998 | $23 |
| Atorvastatin | 108 | $825 | $8 |
| Albuterol Sulfate Hfa | 27 | $812 | $30 |
| Famotidine | 30 | $762 | $25 |
| Losartan | 85 | $742 | $9 |
| Rosuvastatin | 44 | $564 | $13 |
| Tamsulosin | 29 | $517 | $18 |
| Amlodipine Besylate | 68 | $475 | $7 |
| Levothyroxine | 38 | $404 | $11 |
| Fluticasone Propionate | 24 | $402 | $17 |
| Bupropion Xl | 11 | $401 | $36 |
| Diclofenac | 14 | $395 | $28 |
| Esomeprazole Magnesium | 13 | $387 | $30 |
| Solifenacin | 12 | $369 | $31 |
| Donepezil | 20 | $302 | $15 |
| Metformin Hcl Er | 40 | $260 | $6 |
| Simvastatin | 25 | $256 | $10 |
| Lisinopril | 37 | $232 | $6 |
| Nitrofurantoin Mono-Macro | 14 | $230 | $16 |
| Ezetimibe | 12 | $212 | $18 |
| Hydrochlorothiazide | 30 | $202 | $7 |
| Omeprazole | 19 | $186 | $10 |
| Digoxin | 13 | $181 | $14 |
| Metformin | 20 | $180 | $9 |
| Triamcinolone Acetonide | 20 | $178 | $9 |
| Clopidogrel | 15 | $173 | $12 |
| Furosemide | 24 | $166 | $7 |
| Spironolactone | 17 | $152 | $9 |
| Pantoprazole | 11 | $126 | $11 |
| Sertraline | 12 | $102 | $8 |
| Finasteride | 11 | $87 | $8 |
| Pravastatin | 22 | $83 | $4 |
| Metoprolol | 14 | $64 | $5 |
| Alendronate | 14 | $59 | $4 |
Year by year
| 2024 | 1,461 | 164 | None | None | $132,974 |
| 2023 | 1,622 | 166 | None | None | $131,975 |
| 2022 | 1,374 | 161 | None | None | $106,868 |
| 2021 | 1,213 | 163 | None | 12% | $65,979 |
| 2020 | 978 | 125 | 1% (12) | None | $42,009 |
| 2019 | 960 | 146 | 1% (12) | 15% | $64,839 |
| 2018 | 435 | 115 | 4% (17) | None | $32,835 |
| 2017 | 628 | 116 | 7% (42) | 13% | $36,849 |
| 2016 | 203 | 61 | 7% (14) | 15% | $6,676 |
| 2015 | 153 | 33 | None | 13% | $3,680 |
| 2014 | 402 | 55 | None | 17% | $17,180 |
| 2013 | 284 | 69 | None | None | $13,826 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Jardiance | 11 | $16,127 | $1,466 |
| Eliquis | 20 | $11,334 | $567 |
| Myrbetriq | 11 | $7,153 | $650 |
| Qvar Redihaler | 11 | $3,212 | $292 |
| Esomeprazole Magnesium | 12 | $2,466 | $206 |
| Atorvastatin | 138 | $2,017 | $15 |
| Amiodarone | 12 | $1,759 | $147 |
| Rosuvastatin | 51 | $1,536 | $30 |
| Solifenacin | 12 | $1,403 | $117 |
| Gabapentin | 49 | $1,371 | $28 |
| Losartan | 98 | $1,242 | $13 |
| Olmesartan Medoxomil | 16 | $1,171 | $73 |
| Levothyroxine | 64 | $1,164 | $18 |
| Tamsulosin | 57 | $1,070 | $19 |
| Pantoprazole | 16 | $884 | $55 |
| Diclofenac | 30 | $779 | $26 |
| Famotidine | 34 | $658 | $19 |
| Albuterol Sulfate Hfa | 23 | $658 | $29 |
| Fluticasone Propionate | 33 | $637 | $19 |
| Amlodipine Besylate | 78 | $637 | $8 |
| Pravastatin | 20 | $549 | $27 |
| Lactulose | 14 | $416 | $30 |
| Metoprolol | 21 | $381 | $18 |
| Omeprazole | 28 | $337 | $12 |
| Clopidogrel | 14 | $293 | $21 |
| Simvastatin | 19 | $292 | $15 |
| Metformin Hcl Er | 28 | $291 | $10 |
| Lisinopril | 31 | $286 | $9 |
| Digoxin | 12 | $244 | $20 |
| Triamcinolone Acetonide | 24 | $225 | $9 |
| Carvedilol | 12 | $199 | $17 |
| Alendronate | 25 | $186 | $7 |
| Finasteride | 24 | $185 | $8 |
| Nitrofurantoin Mono-Macro | 11 | $157 | $14 |
| Furosemide | 25 | $151 | $6 |
| Metformin | 14 | $131 | $9 |
| Lovastatin | 16 | $127 | $8 |
| Metoprolol | 13 | $112 | $9 |
| Spironolactone | 14 | $99 | $7 |
| Hydrochlorothiazide | 23 | $99 | $4 |
2022: 38 drugs
| Eliquis | 17 | $9,228 | $543 |
| Myrbetriq | 15 | $8,587 | $572 |
| Anoro Ellipta | 18 | $7,832 | $435 |
| Vascepa | 13 | $3,411 | $262 |
| Qvar Redihaler | 12 | $3,380 | $282 |
| Esomeprazole Magnesium | 12 | $2,466 | $206 |
| Gabapentin | 56 | $1,812 | $32 |
| Amiodarone | 12 | $1,624 | $135 |
| Albuterol Sulfate Hfa | 23 | $1,600 | $70 |
| Solifenacin | 12 | $1,542 | $128 |
| Tamsulosin | 58 | $1,317 | $23 |
| Olmesartan Medoxomil | 15 | $1,233 | $82 |
| Atorvastatin | 105 | $1,199 | $11 |
| Levothyroxine | 51 | $981 | $19 |
| Losartan | 73 | $980 | $13 |
| Diclofenac | 25 | $689 | $28 |
| Pantoprazole | 12 | $607 | $51 |
| Rosuvastatin | 29 | $537 | $19 |
| Trazodone | 20 | $452 | $23 |
| Pravastatin | 12 | $437 | $36 |
| Amlodipine Besylate | 57 | $363 | $6 |
| Escitalopram | 14 | $350 | $25 |
| Omeprazole | 33 | $343 | $10 |
| Nitrofurantoin Mono-Macro | 15 | $277 | $18 |
| Famotidine | 17 | $224 | $13 |
| Finasteride | 17 | $211 | $12 |
| Triamcinolone Acetonide | 15 | $162 | $11 |
| Lovastatin | 15 | $154 | $10 |
| Hydrochlorothiazide | 27 | $150 | $6 |
| Lisinopril | 26 | $147 | $6 |
| Metformin | 21 | $139 | $7 |
| Metformin Hcl Er | 12 | $92 | $8 |
| Carvedilol | 14 | $81 | $6 |
| Spironolactone | 11 | $72 | $7 |
| Alendronate | 21 | $57 | $3 |
| Furosemide | 12 | $52 | $4 |
| Simvastatin | 16 | $45 | $3 |
| Lorazepam | 13 | $34 | $3 |
2021: 29 drugs
| Eliquis | 21 | $10,226 | $487 |
| Symbicort | 11 | $4,298 | $391 |
| Vascepa | 12 | $3,006 | $251 |
| Atorvastatin | 101 | $1,289 | $13 |
| Levothyroxine | 54 | $1,021 | $19 |
| Bupropion Xl | 13 | $1,016 | $78 |
| Tamsulosin | 49 | $937 | $19 |
| Rosuvastatin | 17 | $847 | $50 |
| Mirtazapine | 17 | $672 | $40 |
| Losartan | 54 | $654 | $12 |
| Escitalopram | 22 | $629 | $29 |
| Gabapentin | 37 | $628 | $17 |
| Omeprazole | 31 | $438 | $14 |
| Pantoprazole | 14 | $400 | $29 |
| Amlodipine Besylate | 61 | $346 | $6 |
| Trazodone | 23 | $270 | $12 |
| Finasteride | 18 | $268 | $15 |
| Hydrochlorothiazide | 37 | $201 | $5 |
| Pravastatin | 12 | $185 | $15 |
| Simvastatin | 22 | $162 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $149 | $14 |
| Lisinopril | 31 | $130 | $4 |
| Benazepril | 13 | $121 | $9 |
| Metoprolol | 11 | $117 | $11 |
| Metformin Hcl Er | 13 | $113 | $9 |
| Metformin | 13 | $99 | $8 |
| Metoprolol | 14 | $96 | $7 |
| Famotidine | 11 | $81 | $7 |
| Alendronate | 12 | $68 | $6 |
2020: 25 drugs
| Eliquis | 18 | $8,516 | $473 |
| Rosuvastatin | 22 | $1,362 | $62 |
| Atorvastatin | 85 | $1,051 | $12 |
| Albuterol Sulfate Hfa | 15 | $935 | $62 |
| Levothyroxine | 29 | $677 | $23 |
| Losartan | 44 | $664 | $15 |
| Mirtazapine | 23 | $558 | $24 |
| Tamsulosin | 23 | $508 | $22 |
| Gabapentin | 26 | $427 | $16 |
| Pantoprazole | 12 | $307 | $26 |
| Finasteride | 17 | $282 | $17 |
| Amlodipine Besylate | 51 | $268 | $5 |
| Metoprolol | 14 | $264 | $19 |
| Pravastatin | 13 | $250 | $19 |
| Lisinopril | 32 | $226 | $7 |
| Omeprazole | 14 | $195 | $14 |
| Hydrochlorothiazide | 29 | $178 | $6 |
| Promethazine | 12 | $174 | $14 |
| Metformin | 16 | $171 | $11 |
| Alendronate | 13 | $169 | $13 |
| Simvastatin | 20 | $166 | $8 |
| Triamcinolone Acetonide | 11 | $134 | $12 |
| Trazodone | 13 | $80 | $6 |
| Lorazepam | 18 | $45 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $29 | $3 |
2019: 20 drugs
| Eliquis | 25 | $13,486 | $539 |
| Atorvastatin | 64 | $984 | $15 |
| Rosuvastatin | 17 | $735 | $43 |
| Levothyroxine | 34 | $718 | $21 |
| Mirtazapine | 12 | $681 | $57 |
| Metoprolol | 29 | $590 | $20 |
| Ultra-Fine Nano Pen Needle | 12 | $554 | $46 |
| Tamsulosin | 23 | $399 | $17 |
| Losartan | 35 | $370 | $11 |
| Gabapentin | 16 | $367 | $23 |
| Promethazine | 13 | $361 | $28 |
| Omeprazole | 22 | $264 | $12 |
| Lisinopril | 31 | $258 | $8 |
| Sumatriptan | 14 | $253 | $18 |
| Simvastatin | 17 | $197 | $12 |
| Amlodipine Besylate | 36 | $194 | $5 |
| Furosemide | 13 | $125 | $10 |
| Hydrochlorothiazide | 30 | $118 | $4 |
| Triamcinolone Acetonide | 12 | $116 | $10 |
| Lorazepam | 23 | $45 | $2 |
2018: 10 drugs
| Levothyroxine | 21 | $445 | $21 |
| Tamsulosin | 25 | $317 | $13 |
| Atorvastatin | 16 | $265 | $17 |
| Carvedilol | 11 | $257 | $23 |
| Lisinopril | 24 | $209 | $9 |
| Fluticasone Propionate | 12 | $195 | $16 |
| Simvastatin | 21 | $121 | $6 |
| Losartan | 13 | $102 | $8 |
| Amlodipine Besylate | 22 | $91 | $4 |
| Clonidine | 12 | $79 | $7 |
2017: 17 drugs
| Advair Diskus | 11 | $4,625 | $420 |
| Hydrocodone-Acetaminophen | 28 | $550 | $20 |
| Metoprolol | 13 | $413 | $32 |
| Tamsulosin | 20 | $410 | $20 |
| Levothyroxine | 23 | $389 | $17 |
| Atorvastatin | 29 | $355 | $12 |
| Fluticasone Propionate | 17 | $238 | $14 |
| Metformin | 24 | $204 | $9 |
| Losartan | 26 | $176 | $7 |
| Amlodipine Besylate | 24 | $129 | $5 |
| Simvastatin | 29 | $113 | $4 |
| Metoprolol | 13 | $77 | $6 |
| Lisinopril | 14 | $72 | $5 |
| Hydrochlorothiazide | 23 | $69 | $3 |
| Lorazepam | 12 | $66 | $5 |
| Clonidine | 14 | $65 | $5 |
| Alendronate | 11 | $42 | $4 |
2015: 2 drugs
| Amlodipine Besylate | 13 | $73 | $6 |
| Hydrochlorothiazide | 13 | $52 | $4 |
2014: 12 drugs
| Advair Hfa | 12 | $3,619 | $302 |
| Spiriva | 11 | $3,321 | $302 |
| Fluticasone Propionate | 22 | $348 | $16 |
| Metformin | 28 | $267 | $10 |
| Simvastatin | 25 | $198 | $8 |
| Amlodipine Besylate | 20 | $142 | $7 |
| Losartan | 11 | $110 | $10 |
| Metoprolol | 12 | $95 | $8 |
| Hydrochlorothiazide | 26 | $94 | $4 |
| Lisinopril | 14 | $90 | $6 |
| Ranitidine | 11 | $85 | $8 |
| Trazodone | 11 | $51 | $5 |
2013: 6 drugs
| Fluticasone Propionate | 15 | $394 | $26 |
| Amlodipine Besylate | 22 | $247 | $11 |
| Lisinopril | 23 | $192 | $8 |
| Alendronate | 14 | $145 | $10 |
| Atenolol | 11 | $92 | $8 |
| Hydrochlorothiazide | 12 | $74 | $6 |
Professional record
- NPI
- 1467741207
- Licence
- CA A115515California A115515: Current · expires 2028-07-31
- Trained
- University of California, Irvine, California College of Medicine, 2009
- Group
- University Healthcare Alliance · Indian Health Center of Santa Clara Valley
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1003 Leigh Ave, Apartment 2, San Jose, CA, 95128
- NPI first listed
- 2011-04-01
- NPI last updated
- 2011-04-01
This is when the NPI record was last certified, not a medical board exam.